Skip to main content
. 2019 Sep 18;19:823. doi: 10.1186/s12879-019-4460-y

Table 6.

Resistance rates(%) of Acinetobacter baumanii to antimicrobial agents

Antimicrobial agent 2003–2004
(n = 0)
2005–2006
(n = 3)
2007–2008
(n = 6)
2009–2010
(n = 8)
2011–2012
(n = 17)
2013–2014
(n = 2)
Amikacin 66.7 66.7 50.0 64.7 100.0
Gentamicin 100.0 100.0 75.0 82.4 100.0
Piperacillin 100.0 66.7 75.0 88.2 100.0
Piperacillin/taazobactam 100.0 100.0 75.0 88.2 100.0
Cefazolin 100.0 100.0 100.0 100.0 100.0
Cefuroxime 100.0 100.0 100.0 100.0
Cefotaxime 100.0 80.0 75.0 82.4 100.0
Ceftazidime 100.0 60.0 50.0 76.5 50.0
Cefepime 100.0 100.0 50.0 70.6 50.0
Imipenem 33.3 16.7 50.0 64.7 100.0
Meropenem 100.0 0 80.0 75.0 100.0
Ciprofloxacin 100.0 83.3 62.5 70.6 100.0